TY - JOUR T1 - Fluticasone/salmeterol is associated with a higher risk of pneumonia and pneumonia related events in comparison with budesonide/formoterol in patients with COPD JF - Thorax JO - Thorax SP - 996 LP - 996 DO - 10.1136/thoraxjnl-2013-204098 VL - 68 IS - 11 AU - Avais Jabbar Y1 - 2013/11/01 UR - http://thorax.bmj.com/content/68/11/996.abstract N2 - Combination treatment with inhaled corticosteroids and long acting β2 agonists decrease exacerbations and improve quality of life in patients with chronic obstructive pulmonary disease (COPD) however; a potential concern is an increased risk of pneumonia. Although previous studies have shown the risk of pneumonia to increase with fluticasone/salmeterol versus placebo and tiotropium, there has been no direct comparison of fixed combinations of inhaled corticosteroid/long acting β2 … ER -